Maternal Ferritin Levels during Pregnancy and ADHD Symptoms in 4-Year-Old Children: Results from the INMA-INfancia y Medio Ambiente (Environment and Childhood) Prospective Birth Cohort Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
22 10 2020
Historique:
received: 02 10 2020
revised: 16 10 2020
accepted: 19 10 2020
entrez: 27 10 2020
pubmed: 28 10 2020
medline: 23 1 2021
Statut: epublish

Résumé

Ferritin status during prenatal brain development may influence the risk of attention deficit and hyperactivity disorder (ADHD) symptoms in childhood. We investigated the association of maternal ferritin in pregnancy and ADHD-like symptoms in offspring. A total of 1095 mother-child pairs from three birth cohorts of the INMA Project (Spain) were studied. Maternal plasma ferritin in pregnancy was measured at 11.57 weeks of gestation. Children's ADHD-like symptoms at ages 4-5 years were assessed using the ADHD Rating Scale-IV. The count model of the zero-inflated Poisson regression model showed a significant inverse association between ferritin (continuous variable) and inattention, β = -0.19 (-0.32, -0.07), for boys. Comparing ferritin level by tertiles, significant differences were observed between the first tertile ([1.98, 20.92]) and the second ([20.92, 38.79]) and third tertiles ([38.79, 216.5]) (mg/L).The number of symptoms was lower for those in the third tertile, β = -0.3 (-0.55, -0.5), and for those in the second one, β = -0.37 (-0.6, -0.14). The model stratification by sex also showed this inverse association for boys only, β = -0.21 (-0.34, -0.08). No associations were found between ferritin level and hyperactivity or total ADHD symptoms. High ferritin levels during pregnancy show a protective association with child inattentive-type ADHD symptoms.

Identifiants

pubmed: 33105572
pii: ijerph17217704
doi: 10.3390/ijerph17217704
pmc: PMC7659477
pii:
doi:

Substances chimiques

Ferritins 9007-73-2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Références

Child Dev. 2018 Mar;89(2):593-608
pubmed: 28233303
Am J Obstet Gynecol. 2020 Oct;223(4):516-524
pubmed: 32184147
J Child Psychol Psychiatry. 2014 May;55(5):436-45
pubmed: 24274762
J Atten Disord. 2020 Oct;24(12):1637-1647
pubmed: 29039728
Am J Clin Nutr. 1989 Sep;50(3 Suppl):618-25; discussion 625-9
pubmed: 2570524
J Nutr. 1996 Mar;126(3):693-701
pubmed: 8598555
Am J Med Genet B Neuropsychiatr Genet. 2016 Oct;171(7):931-7
pubmed: 26710920
J Nutr. 1995 Jun;125(6):1529-35
pubmed: 7782907
Zhongguo Dang Dai Er Ke Za Zhi. 2011 Sep;13(9):722-4
pubmed: 21924020
Biol Psychiatry. 2005 Jun 1;57(11):1313-23
pubmed: 15950004
BMC Neurosci. 2014 Jan 10;15:9
pubmed: 24410996
Pediatrics. 2015 May;135(5):e1198-209
pubmed: 25917989
Eur J Radiol. 2007 Apr;62(1):138-42
pubmed: 17161570
Physiol Rep. 2017 Mar;5(6):
pubmed: 28325789
PLoS One. 2013 Sep 23;8(9):e74876
pubmed: 24086390
Curr Neurovasc Res. 2010 Feb;7(1):15-22
pubmed: 20158466
J Atten Disord. 2012 Apr;16(3):190-8
pubmed: 22290696
Eur Child Adolesc Psychiatry. 2019 Apr;28(4):481-489
pubmed: 30097723
Curr Opin Pediatr. 2016 Aug;28(4):559-66
pubmed: 27386975
PLoS One. 2017 Jan 3;12(1):e0169145
pubmed: 28046016
J Neurochem. 1986 Jun;46(6):1670-4
pubmed: 2871128
Neurotherapeutics. 2012 Jul;9(3):490-9
pubmed: 22976615
Am J Psychiatry. 2002 Jan;159(1):36-42
pubmed: 11772687
J Atten Disord. 2003 Nov;7(2):93-100
pubmed: 15018358
BMC Psychiatry. 2016 Aug 31;16:306
pubmed: 27581195
BBA Clin. 2016 Oct 18;6:153-158
pubmed: 27896136
Med Hypotheses. 2012 Aug;79(2):246-9
pubmed: 22632845
Biol Psychiatry. 2005 Jun 1;57(11):1215-20
pubmed: 15949990
Behav Neurol. 2018 Nov 29;2018:8932817
pubmed: 30631381
Front Hum Neurosci. 2019 Feb 11;13:42
pubmed: 30804772
Lancet. 2006 Dec 16;368(9553):2167-78
pubmed: 17174709
Am J Psychiatry. 2007 Jun;164(6):942-8
pubmed: 17541055
Neuropsychol Rev. 2007 Mar;17(1):39-59
pubmed: 17318414
Clin Neurophysiol. 2006 Feb;117(2):243-51
pubmed: 16376608
J Child Psychol Psychiatry. 2016 Apr;57(4):532-7
pubmed: 26511313
Neurotoxicol Teratol. 2005 May-Jun;27(3):395-406
pubmed: 15939200
Annu Rev Nutr. 2003;23:41-58
pubmed: 12704220
Epidemiology. 2015 Jul;26(4):458-65
pubmed: 25867115
Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):261-84, vii-viii
pubmed: 18295146
Ann Neurol. 1992;32 Suppl:S51-61
pubmed: 1510381
Dev Psychopathol. 2008 Fall;20(4):1161-75
pubmed: 18838036
Ann Med Health Sci Res. 2014 Sep;4(Suppl 3):S291-7
pubmed: 25364604
Mitochondrion. 2019 Jul;47:174-178
pubmed: 30423452
Expert Rev Neurother. 2012 Oct;12(10):1227-40
pubmed: 23082739
Neurotox Res. 2003;5(1-2):1-26
pubmed: 12832221
Oxid Med Cell Longev. 2015;2015:725370
pubmed: 26106458
Mitochondrion. 2019 Nov;49:83-88
pubmed: 31349020
Med Hypotheses. 2008;70(6):1128-32
pubmed: 18164140
J Nutr. 1997 Dec;127(12):2282-8
pubmed: 9405575
Nutrients. 2019 Dec 07;11(12):
pubmed: 31817835
BJOG. 2016 Dec;123(13):2094-2103
pubmed: 26996156
J Child Psychol Psychiatry. 2013 Jan;54(1):3-16
pubmed: 22963644
Brain Sci. 2018 Aug 13;8(8):
pubmed: 30104506
J Nutr. 2000 Nov;130(11):2831-7
pubmed: 11053528
Sci Rep. 2018 Jan 15;8(1):788
pubmed: 29335588
Biometals. 2012 Aug;25(4):761-76
pubmed: 22318507
Pediatrics. 2013 Dec;132(6):e1649-58
pubmed: 24249815
Evid Based Ment Health. 2012 May;15(2):36
pubmed: 22345104
Nutr Rev. 2011 Nov;69 Suppl 1:S43-8
pubmed: 22043882
Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):285-307, viii
pubmed: 18295147
Pediatr Neurol. 2002 Aug;27(2):85-92
pubmed: 12213607
Lancet. 2005 Jul 16-22;366(9481):237-48
pubmed: 16023516
Curr Opin Obstet Gynecol. 2000 Dec;12(6):519-24
pubmed: 11128416
JAMA Psychiatry. 2019 Dec 1;76(12):1294-1304
pubmed: 31532497
Lancet Neurol. 2014 Oct;13(10):1045-60
pubmed: 25231526
J Neurochem. 1985 Oct;45(4):999-1005
pubmed: 2993525
Nutr Rev. 2006 May;64(5 Pt 2):S34-43; discussion S72-91
pubmed: 16770951
Pediatrics. 2017 Feb;139(2):
pubmed: 28138005
J Pediatr. 2002 Feb;140(2):165-70
pubmed: 11865266
Cell Mol Biol (Noisy-le-grand). 2000 May;46(3):491-500
pubmed: 10872737
Mov Disord. 2008 Jun 15;23(8):1184-7
pubmed: 18442125

Auteurs

Loreto Santa-Marina (L)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
Biodonostia, Epidemiology and Public Health Area, Environmental Epidemiology and Child Development Group, 20014 San Sebastian, Spain.
Public Health Division of Gipuzkoa, Basque Government, 20013 San Sebastian, Spain.

Nerea Lertxundi (N)

Biodonostia, Epidemiology and Public Health Area, Environmental Epidemiology and Child Development Group, 20014 San Sebastian, Spain.
Faculty of Psychology, University of the Basque Country (UPV/EHU), Avenida Tolosa 70, 20018 San Sebastian, Spain.

Ainara Andiarena (A)

Biodonostia, Epidemiology and Public Health Area, Environmental Epidemiology and Child Development Group, 20014 San Sebastian, Spain.
Faculty of Psychology, University of the Basque Country (UPV/EHU), Avenida Tolosa 70, 20018 San Sebastian, Spain.

Amaia Irizar (A)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
Biodonostia, Epidemiology and Public Health Area, Environmental Epidemiology and Child Development Group, 20014 San Sebastian, Spain.
Faculty of Medicine and Nursing, University of the Basque Country (UPV/EHU), Barrio Sarriena s/n, 48940 Leioa, Spain.

Jordi Sunyer (J)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
Hospital del Mar Research Institute, 08003 Barcelona, Spain.
ISGlobal-Instituto de Salud Global de Barcelona-Campus MAR, PRBB, 08003 Barcelona, Spain.

Amaia Molinuevo (A)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.

Sabrina Llop (S)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, 08003 València, Spain.

Jordi Julvez (J)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
ISGlobal-Instituto de Salud Global de Barcelona-Campus MAR, PRBB, 08003 Barcelona, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Hospital Universitari Sant Joan de Reus, 43204 Reus, Spain.

Andrea Beneito (A)

Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, 08003 València, Spain.

Jesús Ibarluzea (J)

Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, C/Monforte de Lemos 3-5, 28029 Madrid, Spain.
Biodonostia, Epidemiology and Public Health Area, Environmental Epidemiology and Child Development Group, 20014 San Sebastian, Spain.
Public Health Division of Gipuzkoa, Basque Government, 20013 San Sebastian, Spain.
Faculty of Psychology, University of the Basque Country (UPV/EHU), Avenida Tolosa 70, 20018 San Sebastian, Spain.

Liher Imaz (L)

Public Health Division of Gipuzkoa, Basque Government, 20013 San Sebastian, Spain.
Biodonostia, Epidemiology and Public Health Area, Epidemiology of Chronic and Communicable Diseases Group, 20014 San Sebastian, Spain.

Maite Ferrin (M)

Haringey Child and Adolescent Mental Health Service, Barnet, Enfield and Haringey NHS Mental Health Trust, London N15 3TH, UK.
Recognition Health, London W1G 9RU, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH